Expression of E2A-PBX1 affects the central regulatory path of the hematopoietic process, affecting signaling molecules such as WNT, cell cycle control signals, or apoptosis, which contributes to the development and progression of hematologic malignancies (Diakos et al., 2014) (Figure 3). The gene discussed is PBX1; the disease is hematologic disorder.